Company Description
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure.
Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N.
Ltd. in July 2020. Inspira Technologies Oxy B.H.N.
Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.
| Country | Israel |
| Founded | 2018 |
| IPO Date | Jul 14, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 37 |
| CEO | Dagi Shahar Ben-Noon |
Contact Details
Address: Hatidhar 2, 11th Floor Ra'anana, L3 4366504 Israel | |
| Phone | 972-9-9664488 |
| Website | inspira-technologies.com |
Stock Details
| Ticker Symbol | IINN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.51 |
| CIK Code | 0001837493 |
| CUSIP Number | M53637100 |
| ISIN Number | IL0011715781 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer and Director |
| Joe Hayon | Co-Founder, President and Director |
| Yafit Tehila | Chief Financial Officer |
| Avi Shabtai | Chief Operating Officer and Vice President of Research and Development |
| Daniella Yeheskely-Hayon Ph.D. | Chief Technology Officer |
| Meshira Greenberg | Administrative Manager |
| Adi Shmueli | Marketing and Communications Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2024 | 6-K | Report of foreign issuer |
| Apr 10, 2024 | 6-K | Report of foreign issuer |
| Apr 9, 2024 | 6-K | Report of foreign issuer |
| Apr 3, 2024 | 6-K | Report of foreign issuer |
| Apr 1, 2024 | 424B5 | Filing |
| Apr 1, 2024 | 6-K | Report of foreign issuer |
| Mar 25, 2024 | 6-K | Report of foreign issuer |
| Mar 25, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Mar 18, 2024 | 6-K | Report of foreign issuer |
| Mar 15, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |